Prediabetes Neuropathy: Can You Have Neuropathy Before Diabetes? A Surgeon Explains
In some people, blood sugar can still read “normal” while the smallest nerves in the feet may already be under strain. The problem often begins with metabolic dysfunction, not diabetes.
“In the operating room I see the end stage of a process that started years earlier. By the time a nerve is visibly damaged, the metabolic injury that set it in motion has usually been quietly underway for a long time. The question I want patients asking is not ‘Am I diabetic yet?’ It is ‘Is my metabolism already stressing my nerves?’”
Prediabetes neuropathy refers to nerve injury, often involving the small nerve fibers, that can start before a person is formally diagnosed with diabetes because the metabolic dysfunction behind prediabetes may already be stressing the nerves.
Most people believe the sequence is simple. You develop diabetes, your blood sugar climbs, and eventually the high sugar damages your nerves. That story is not wrong. It is just incomplete, and the missing part matters more than almost anything else in nerve health, especially for adults noticing burning, tingling, numbness, or other early signs of neuropathy, and for those trying to protect metabolic health before more damage develops.
Here is the part that gets left out. In some people, nerve injury may begin during the metabolic transition toward diabetes, before formal diagnostic criteria are met. The metabolic dysfunction that eventually becomes type 2 diabetes, the insulin resistance, the high circulating insulin, the oxidative stress, the low-grade inflammation, can be present for years before a fasting glucose or A1c crosses the diagnostic line. And a growing body of evidence suggests that in some people, the smallest nerve fibers are already being affected during that window.
This is not a diabetes article, and it is not another “high blood sugar damages nerves” article. It exists to answer one question with the depth it deserves: can someone develop neuropathy before they are actually diabetic? The honest, evidence-aware answer is that prediabetes does not guarantee neuropathy, but metabolic dysfunction associated with prediabetes may contribute to nerve injury in some individuals, particularly small fiber neuropathy, before diabetes is formally diagnosed. That distinction changes when you should pay attention, because there is an earlier window to identify risk, reduce further injury, and support nerve health with targeted lifestyle changes and evidence-based nutritional support.
Diabetes Does Not Appear Overnight
The single most useful thing to understand about type 2 diabetes is that it is not a switch. It is a slope. Long before a fasting glucose reaches 126 mg/dL or an A1c hits 6.5 percent, the body has usually spent years compensating for a problem that started much earlier: insulin resistance.
Insulin resistance means your cells respond less efficiently to insulin, so the pancreas compensates by producing more of it. For a while, this works. Blood sugar stays in a range that looks acceptable on standard labs. But the price of that normal-looking glucose is chronically elevated insulin, a state called hyperinsulinemia, along with the metabolic turbulence that travels with it: rising oxidative stress, low-grade inflammation, disordered lipid handling, and impaired function of the small blood vessels that feed your tissues. This is the environment your nerves are living in during the years when everyone, including many clinicians, assumes nothing is wrong.
By the time blood sugar climbs into the diabetic range, the metabolic dysfunction underneath it is frequently well established. That is the crucial reframe. Diabetes is a late milestone in a long process, not the beginning of one. For a mechanism-level look at how elevated glucose specifically injures nerve tissue, see our companion article on how high blood sugar damages nerves. What follows here is the story of what happens before that stage.
Tingling feet, but your bloodwork says you're fine?
My free guide explains the insulin–nerve connection: why fasting glucose and A1c can look normal while nerves are already under metabolic stress, the three levers you control, and the questions to bring to your next appointment.
Get the Free Guide →Prediabetes Is Not Always “Mild”
Patients hear a version of the same sentence all the time. “Your sugar is only a little high.” The word only does a lot of quiet damage. It tells people that a borderline number is a borderline problem, and that there is nothing to do until it gets worse.
The more accurate framing is that prediabetes is an increased-risk state shaped by broader metabolic risk factors, not a lighter shade of diabetes. It marks a metabolism that is already struggling to keep glucose and insulin in balance. The value of catching it is not that it is trivial. It is that it is early, because those first changes can be important warning signs and because early interventions have the most leverage at this stage. Nerves respond to the environment they sit in, and the prediabetic environment is measurably different from a healthy one even when the glucose number looks reassuring.
Prediabetes is best understood as an increased-risk state rather than “almost diabetes.” The metabolic dysfunction it reflects can be affecting nerves and small blood vessels while standard glucose numbers still read close to normal.
Why the Smallest Nerve Fibers Appear Vulnerable First
Peripheral nerves are not uniform. They carry a mix of fibers, and those fibers differ in size and in whether they are wrapped in the insulating layer called myelin. The large, heavily myelinated fibers handle vibration sense, position sense, and motor signals. The small fibers, many of them thinly myelinated or unmyelinated, carry pain, temperature, and much of the autonomic signaling that runs your sweat glands, blood vessels, and gut.
Those small unmyelinated fibers appear to be among the earliest casualties of metabolic stress in some individuals. They are long, they are metabolically demanding, and their distal endings in the skin of the feet sit at the far end of the supply line, which makes them sensitive to disruptions in energy and blood flow. When they are affected first, the result is a very specific and often confusing clinical picture: real symptoms with reassuring standard testing.
This is where the diagnostic trap lives. Electromyography and standard nerve conduction studies primarily evaluate the large fibers. Early neuropathic symptoms such as burning or tingling can be present even when standard testing misses them. So a person can have genuine burning, tingling, or pain from small fiber involvement and still be told their EMG is normal, which does not rule out nerve damage. The test can read as normal because it primarily evaluates large fibers, while early disease may affect the small fibers more prominently.
The evidence that small fibers are involved early is not just theoretical. A systematic review of 29 studies covering more than 9,000 participants found that neuropathy is more common in prediabetes than in the background population, and that it is predominantly of small nerve fiber origin (Kirthi et al., systematic review). Studies using skin biopsy and corneal nerve imaging have detected small fiber abnormalities in people with impaired glucose tolerance before they progressed to type 2 diabetes (Azmi et al.). Small fiber involvement is not universal in prediabetes, and estimates vary widely depending on the population and the testing method used. But the pattern is consistent enough to take seriously.
A Normal A1c or Blood Sugar Does Not Tell the Whole Story
This is probably the most important practical point in the entire article, so it is worth being precise. Fasting glucose and A1c are genuinely useful tests. They are the backbone of diabetes screening for good reason, and nothing here should be read as a reason to ignore them. But they each capture only one slice of a complex system, and neither was designed to detect early nerve-relevant metabolic dysfunction.
A1c reflects an average of blood glucose over roughly three months. An average can hide a lot. Two people with an identical A1c can have very different day-to-day glucose behavior, and different degrees of insulin resistance, glucose intolerance, and post-meal abnormalities sitting underneath that number. Fasting glucose, measured after an overnight fast, can look fine in someone whose glucose spikes substantially after meals.
Different measures reflect different aspects of glucose metabolism, and several of them tend to shift before fasting glucose and A1c move much at all. Without turning this into an endocrinology lecture, the concepts worth knowing are post-meal glucose, which can reveal problems an overnight fasting number misses; insulin resistance itself, which can be present for years while glucose stays compensated; and glucose variability, the size of the swings rather than the average. A person can have a normal A1c and still be living with meaningful metabolic dysfunction. We go deeper into the thresholds in our piece on at what A1c nerve damage actually starts.
A normal A1c is reassuring, but it is an average that can miss post-meal spikes, glucose variability, and the insulin resistance that often precedes any change in fasting glucose. “My A1c is normal” does not, by itself, rule out early metabolic nerve stress.
Why Nerves May Be Damaged Before Diabetes: The Cellular Mechanisms
It is tempting to compress all of this into “high glucose damages nerves.” That phrase is true in diabetes, but it is too narrow to explain why nerves can be affected before glucose is even high. The better explanation is that nerve injury in early metabolic dysfunction is multifactorial. Several overlapping processes converge on the same vulnerable target: the energy-hungry distal ending of a small nerve fiber.
The mechanisms most relevant here include oxidative stress, an imbalance between damaging reactive oxygen species and the antioxidant defenses that neutralize them; mitochondrial dysfunction, in which the cellular power plants that nerves depend on become less efficient at producing energy; chronic low-grade inflammation, driven in part by excess adipose tissue and disordered metabolism; impaired blood vessel function in the tiny vasa nervorum that feed the nerves; advanced glycation, the formation of harmful advanced glycation end-products (AGEs) when sugars react with proteins, a contributor that tends to grow as glycemia worsens; and altered lipid metabolism, which is why abnormal triglycerides and other lipid problems, not glucose alone, are associated with neuropathy. Underneath much of it, in our clinical interpretation, runs a common thread: reduced nerve energy production. A nerve fiber that cannot make enough ATP to maintain and repair its most distal reaches is a nerve fiber that begins to withdraw.
This is exactly why the field increasingly frames the driver as metabolic dysfunction rather than blood sugar in isolation. The components of the metabolic syndrome, including obesity, elevated triglycerides, and high blood pressure, have each been associated with peripheral nerve dysfunction, sometimes independently of glucose (Stino & Smith review). In the PROMISE cohort, which followed adults at high metabolic risk, neuropathy was present in 29% of those with normal glucose, 49% of those with prediabetes, and 50% of those with new-onset diabetes, and mean vibration perception thresholds rose in parallel (6.5 V, 7.9 V, and 7.6 V). Those are figures from a high-risk sample, not general-population rates. Looking more broadly, a systematic review reported neuropathy prevalence in prediabetes ranging widely from 2% to 77% depending on the methods and populations studied, with 72% of studies reporting at least 10%. The nerve is responding to its whole metabolic environment, not to a single lab value.
Supporting the Cellular Terrain Nerves Depend On
Once you see nerve injury as an energy-and-oxidation problem rather than only a sugar problem, the logic of nutritional support becomes clearer, and so do its limits. Supporting the cellular terrain does not replace addressing the root cause, which is the metabolic dysfunction itself. But the same mechanisms that stress nerves early are, in principle, the mechanisms that targeted nutritional cofactors are designed to support.
This is the design logic behind NeuroAxis, the nerve support supplement I developed to map onto these specific pathways rather than to chase a single ingredient. R-alpha-lipoic acid and N-acetyl-cysteine support the antioxidant and glutathione systems that counter oxidative stress, while coenzyme Q10 reinforces the mitochondrial electron transport chain. Acetyl-L-carnitine and benfotiamine, a fat-soluble form of vitamin B1, support the energy metabolism that distal fibers run on, and benfotiamine has been studied for its effects on AGE-related pathways. Methylcobalamin, the active form of vitamin B12, supports myelin maintenance and is involved in homocysteine metabolism, a marker of vascular and nerve stress. Curcumin and the systemic enzymes are included to support a healthy inflammatory balance in the tissue environment around the nerve. In other words, the formula is built to support cellular energy production and antioxidant defense, the exact levers this article has been describing. It is supportive, not curative, and it belongs alongside the metabolic work, not in place of it. For the broader framework, see our physician’s guide to what a nerve supplement should contain.
Why I formulated NeuroAxis
The same pathways that come under strain in early metabolic dysfunction are the ones nutrition can support. Nerves depend on several nutritional pathways at once: energy production, antioxidant defense, and myelin support. NeuroAxis combines R-alpha-lipoic acid, benfotiamine, methylcobalamin, and other researched nutrients in a single multi-pathway formula, designed to complement the metabolic work, not replace it.*
Every order also includes the 160-page NeuroAxis Protocol, my guide to the nutrition and lifestyle pillars that come before any supplement.
See NeuroAxis + the 160-Page Protocol →*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
What the Symptoms Actually Feel Like
Because small fibers carry pain and temperature, early symptoms tend to be sensory and tend to start in the feet, where the longest fibers end. People describe burning, tingling, numbness, brief electric sensations, and altered temperature perception, often beginning as mild symptoms. Some develop allodynia, in which a normally painless stimulus like a bedsheet feels painful. The symptoms are often worse at night and often symmetric, affecting both feet in a similar pattern, which is the most common type of diabetic peripheral nerve involvement. As nerve involvement advances, some people also notice weakness.
What makes this frustrating is that the symptoms can be very real while the physical exam and standard tests look unremarkable, especially early. That mismatch leads some people to be told the problem is not nerve-related at all. Persistent symptoms can also start to interfere with daily activities. It is worth remembering that not every burning foot is neuropathy, and other causes deserve consideration, which we cover in burning feet, causes beyond neuropathy. The goal is not to self-diagnose from a symptom list. It is to know that these sensations, in the right metabolic context, deserve a real evaluation rather than a shrug.
How Early Nerve Involvement Is Evaluated
Evaluating possible neuropathy in a prediabetic or metabolically stressed person means looking at both the metabolic picture and the nerve picture, because either one alone can mislead. A thoughtful workup generally combines several layers.
It starts with a careful history and a focused exam, including simple bedside tests of sensation such as monofilament testing and vibration sense; in some cases, a structured tool like the Michigan Neuropathy Screening Instrument may also be used. It includes blood work that goes beyond a single fasting glucose, because the metabolic context is central, and because it is important to rule out other treatable contributors to neuropathy such as B12 deficiency and thyroid disease, while also considering whether medication-related nerve injury could be a side effect. When large fiber involvement is in question, nerve conduction studies and EMG have a role, with the caveat already discussed that they can be normal in pure small fiber disease. When the picture points to small fibers specifically, a skin biopsy measuring intraepidermal nerve fiber density can document the involvement that EMG cannot. The right combination depends on the person, which is precisely why this is a conversation to have with a clinician who takes early nerve symptoms seriously rather than dismissing them because a glucose number looks acceptable.
Can Early Nerve Changes Improve?
This is the question everyone actually wants answered, so it deserves a careful answer rather than an inspiring one. The responsible framing is this: addressing the underlying metabolic dysfunction may help reduce further nerve injury and, in some individuals, improve symptoms and even measures of nerve health. That is meaningfully different from promising reversal, and the difference is not hedging for its own sake. It is what the evidence supports.
The most encouraging data come from the early, metabolic end of the spectrum, which is the whole reason catching this early matters. In a lifestyle-intervention study of people with impaired glucose tolerance and neuropathy, roughly a year of diet and exercise counseling modeled on diabetes-prevention programs was associated with an increase in intraepidermal nerve fiber density, the skin-biopsy measure of small fiber health, along with improvement in pain in many participants (Smith et al., Diabetes Care). Later work found that supervised exercise could improve the capacity of skin nerves to reinnervate in people with metabolic syndrome (Singleton et al., Annals of Neurology). These are not miracle results, and they do not apply to everyone or every stage. But they suggest that early small fiber changes are not necessarily a one-way street, which is a genuinely hopeful and evidence-based message. For the fuller picture, see can you reverse neuropathy, what the science actually says.
The levers that matter are unglamorous and powerful. Weight loss when appropriate, regular exercise, a nutrition pattern that reduces glucose and insulin load, adequate sleep, smoking cessation, and attention to blood pressure and lipids all act on the same metabolic dysfunction that stresses nerves. Tightly managing blood sugar can help prevent diabetic neuropathy, and the American Diabetes Association often recommends an A1C target of less than 7.0% for many adults, individualized with clinician guidance. This is where metabolic health, nerve health, and ongoing diabetes care stop being separate topics. Nutritional cofactors that support nerve energy and antioxidant defense, including alpha-lipoic acid and the B vitamins, can play a supportive role, but they work best as a complement to the metabolic changes, not a substitute for them. What you eat day to day is foundational, and our neuropathy diet guide lays out the specifics.
If you are having burning, tingling, or numbness in your feet but were told your sugar is fine, this is a reasonable, non-alarmist path to bring to your clinician:
1. Ask about metabolic testing beyond a single fasting glucose, since post-meal glucose and markers of insulin resistance can be abnormal earlier.
2. Ask whether your symptoms fit a small fiber pattern, and remember a normal EMG does not settle the question.
3. Ask to rule out other treatable causes, including B12 deficiency and thyroid dysfunction.
4. Ask which metabolic contributors and treatment priorities to track, including glucose patterns, lipids, and body mass index.
5. Start the metabolic levers now rather than waiting for a diabetes diagnosis, because early is where the leverage is.
Take your symptoms seriously. Write down what you feel, where, and when it is worst. A specific symptom log is worth more than a vague memory at your appointment.
Move daily. Even walking after meals blunts glucose spikes. Cut the largest sources of refined carbohydrate from your day.
Get a proper evaluation of both your metabolic and nerve health. Build a sustainable exercise and nutrition routine rather than a crash plan.
Treat metabolic health as ongoing maintenance, not a one-time fix. Recheck your metabolic markers, track your symptoms, and keep the levers in place.
The Biggest Misconceptions and Risk Factors, Corrected
Some of the most common beliefs about nerves and blood sugar are precisely the ones that delay people from acting. Each of these deserves a direct correction.
“My A1c is normal, so it can’t be neuropathy.”
A1c is a three-month average that can miss post-meal spikes, glucose variability, and insulin resistance. A normal A1c lowers the probability of a glucose-driven problem but does not eliminate the possibility of early metabolic nerve stress.
“Only diabetics get neuropathy.”
Neuropathy has many causes, and metabolic dysfunction short of diabetes is associated with a higher prevalence of nerve involvement than in the general population. Diabetes is one important cause, not the only one.
“If my EMG is normal, I don’t have nerve damage.”
EMG and nerve conduction studies primarily assess large fibers. Small fiber neuropathy can be present with a completely normal EMG, which is why the test cannot rule it out on its own.
“Prediabetes isn’t serious.”
Prediabetes is an increased-risk state that reflects real metabolic dysfunction. It is not a reason to panic, but it is a reason to act, and it is the stage where intervention has the most leverage.
In the operating room, advanced nerve damage is the end of a long story. The most valuable window is at the beginning, in the metabolic phase, when the smallest fibers are stressed but not yet lost. That is the window this article is asking you not to miss.
Frequently Asked Questions
Can you have neuropathy before being diagnosed with diabetes?
Yes, it is possible. Prediabetes does not guarantee neuropathy, but research suggests that some people develop nerve injury, particularly small fiber neuropathy, before meeting the diagnostic criteria for diabetes. The metabolic dysfunction that precedes diabetes appears to be able to affect nerves during that earlier window.
Is peripheral neuropathy common in prediabetes?
Studies report a higher prevalence of peripheral neuropathy in prediabetes than in people with normal glucose, but the estimates vary widely depending on the population studied and the diagnostic methods used. What is fairly consistent is that when nerve involvement is found in prediabetes, it is often of small fiber origin.
Why is my EMG normal if I have nerve symptoms?
Standard EMG and nerve conduction studies mainly measure large, myelinated nerve fibers. Small fiber neuropathy affects the smaller pain and temperature fibers, which those tests do not assess well, so an EMG can be normal even when small fiber symptoms are real. A skin biopsy is one way to evaluate small fibers specifically.
Can early nerve damage from prediabetes be reversed?
Reversal is not guaranteed, and the honest answer avoids overpromising. However, addressing the underlying metabolic dysfunction through diet, exercise, and weight management has been associated with improvement in small fiber measures and symptoms in some studies, especially when caught early. The realistic goal is to reduce further injury and, in some people, improve nerve health.
Do supplements help with early metabolic nerve stress?
Nutritional cofactors that support nerve energy metabolism and antioxidant defense can play a supportive role, but they are not a replacement for medical evaluation or for addressing the metabolic root cause. They work best alongside the metabolic changes that do the heavy lifting. Anyone with new or persistent nerve symptoms should be properly evaluated rather than relying on supplements alone, especially since diabetic neuropathy is estimated to affect up to about half of people with diabetes over time and can contribute to foot problems, sores, ulcers, infections, and other complications that may ultimately require surgery. At minimum, schedule foot exams at least once a year as part of ongoing monitoring.
Where to go from here
Explore NeuroAxis: the multi-pathway nerve support formula I developed, with the 160-page NeuroAxis Protocol included.*
Get the free Nerve Health Blueprint: my nutrition and lifestyle framework.
Book a free 10-minute discovery call: talk through your situation directly.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Dr. Michael Fitzmaurice is a fellowship-trained peripheral nerve surgeon with a background in nerve physiology, metabolic health, and applied exercise physiology. Through years of surgical practice, he has observed the close relationship between metabolic health, cellular energy production, and nervous system function. His work focuses on how physical activity, recovery biology, and nutrition-informed strategies relate to long-term nerve and metabolic health.
He oversees Dr. Fitz Nutrition, an education-first initiative translating evidence-informed research into thoughtfully designed formulations for nerve and metabolic health, and believes that patients who understand the science make better decisions about their care.
This content is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. Always consult a qualified healthcare provider regarding your individual medical situation.